XBIO Xenetic Biosciences, Inc. - Common Stock
$3,25
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$2–$14
11% of range
Calificación del Analista
HOLD
6 analysts
Precio Objetivo
—
P/E (TTM)
-1.4
ROE
—
Margen de Beneficio Neto
—
Acerca de Xenetic Biosciences, Inc. - Common Stock Descripción general de la empresa de Wikipedia
XBIO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.25
Capitalización Bursátil
—
P/E (TTM)
-1.4
BPA (TTM)
$-1.58
Ingresos (TTM)
$3M
Rendimiento div.
—
ROE
—
Deuda/Capital
—
Rango 52S
$2 – $14
XBIO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$3M
2016-12-31
→
2025-12-31
BPA
$-1.58
2021-12-31
→
2025-12-31
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
XBIO
Mediana de Pares
P/E (TTM)
-1.4
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
XBIO
Mediana de Pares
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
XBIO
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
XBIO
Mediana de Pares
Revenue YoY (Ingresos interanuales)
19.0%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
20.4%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
46.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
XBIO
Mediana de Pares
XBIO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
VENTA
6 analistas
- Compra fuerte 0 0,0%
- Compra 0 0,0%
- Mantener 3 50,0%
- Venta 1 16,7%
- Venta fuerte 2 33,3%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.07%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2025 | $-0.45 | $-0.65 | 0.20% |
| 31 de marzo de 2025 | $-0.59 | $-0.73 | 0.14% |
| 31 de diciembre de 2024 | $-0.68 | $-0.20 | -0.48% |
| 30 de septiembre de 2024 | $-0.28 | $-0.14 | -0.14% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| XBIO | — | -1.4 | 19.0% | — | — | — |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | — |
| CDIO | — | — | — | — | — | — |
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
| PMCB | $8M | -0.3 | — | — | -56.7% | — |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| DRMA | — | — | — | — | — | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| LABT | — | — | — | — | — | — |
| BCAB | — | -0.6 | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $3M | $3M | $2M | $1M | $436.9K | $17.1K | $0 | $8M | $3M | $0 | $0 | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| R&D Expense | $3M | $3M | $3M | $5M | $3M | $2M | $5M | $3M | $4M | $44M | $3M | $6M | |
| SG&A Expense | $3M | $3M | $4M | $4M | $4M | $3M | $5M | $4M | $7M | $7M | $6M | $7M | |
| Operating Expenses | $6M | $7M | $7M | $8M | $7M | $14M | $13M | $7M | · | · | · | $13M | |
| Operating Income | $-3M | $-4M | $-5M | $-7M | $-6M | $-14M | $-13M | $-7M | $-4M | $-47M | $-10M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1.8K | $729.6K | $267.0K | $4.7K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $5.7K | $-5.7K | $25.4K | $-1.6K | $1.1K | $-492 | $3.3K | $-24.6K | $-24.6K | $-85.4K | $-235.4K | $-326.9K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $-3M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-4M | $-4M | $-7M | $-6M | $-11M | $-13M | $-7M | $-4M | $-54M | $-13M | $-14M | |
| EPS (Basic) | $-1.58 | $-2.57 | $-2.71 | $-4.61 | $-0.55 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.58 | $-2.57 | $-2.71 | $-4.61 | $-0.55 | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,701,571 | 1,541,339 | 1,528,210 | 1,422,443 | 10,279,408 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 1,701,571 | 1,541,339 | 1,528,210 | 1,422,443 | 10,279,408 | · | · | · | · | · | · | · |
Balance general 25
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $6M | $9M | $13M | $18M | $12M | $10M | $571.6K | $6M | $4M | $132.2K | $3M | |
| Receivables | · | · | · | · | · | · | · | · | $0 | $3M | $0 | · | |
| Prepaid Expense | $166.3K | $422.0K | $603.8K | $556.1K | $479.4K | $842.0K | $722.1K | $555.9K | $285.0K | $1M | $247.3K | $204.0K | |
| Current Assets | $8M | $7M | $10M | $14M | $19M | $12M | $11M | $1M | $6M | $8M | $4M | $3M | |
| PP&E (Net) | · | · | · | $0 | $0 | $0 | $757 | $5.0K | $27.8K | $42.4K | $62.0K | $119.4K | |
| PP&E (Gross) | · | · | · | $0 | $50.2K | $57.0K | $57.0K | $89.4K | $358.3K | $349.1K | $332.3K | $586.1K | |
| Accum. Depreciation | · | · | · | $0 | $50.2K | $57.0K | $56.3K | $84.4K | $330.5K | $306.7K | $270.2K | $466.7K | |
| Goodwill | · | · | · | · | · | $0 | $9M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $313.9K | $313.9K | $1M | $1M | $1M | $810.0K | $1M | $705.7K | $724.7K | $66.3K | $129.3K | $199.3K | |
| Total Assets | $8M | $7M | $11M | $15M | $20M | $13M | $22M | $14M | $19M | $21M | $17M | $16M | |
| Accounts Payable | $258.1K | $283.6K | $240.8K | $287.4K | $362.5K | $327.4K | $931.1K | $934.1K | $786.8K | $1M | $2M | $852.8K | |
| Accrued Liabilities | $709.9K | $610.6K | $568.8K | $785.8K | $1M | $574.0K | $464.0K | $664.0K | $1M | $838.9K | $1M | $1M | |
| Current Liabilities | $968.0K | $894.3K | $809.6K | $1M | $1M | $936.9K | $1M | $2M | $2M | $2M | $7M | $3M | |
| Capital Leases | · | · | · | · | · | $27.0K | $0 | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | $27.0K | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $19.9K | $38.8K | $56.4K | |
| Total Liabilities | $968.0K | $894.3K | $809.6K | $1M | $1M | $964.0K | $4M | $5M | $5M | $5M | $10M | $6M | |
| Common Stock | $2.3K | $1.5K | $1.5K | $1.5K | $13.5K | $8.8K | $6.1K | $811 | $9.0K | $8.7K | $4.9K | $150.0K | |
| Paid-in Capital | $212M | $208M | $208M | $208M | $206M | $194M | $188M | $168M | $165M | $164M | $100M | $91M | |
| Retained Earnings | $-200M | $-197M | $-193M | $-189M | $-183M | $-177M | $-166M | $-153M | $-146M | $-142M | $-88M | $-76M | |
| Treasury Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| AOCI | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $575.7K | |
| Stockholders' Equity | $7M | $6M | $10M | $14M | $18M | $12M | $17M | $10M | $14M | $16M | $7M | $10M | |
| Liabilities + Equity | $8M | $7M | $11M | $15M | $20M | $13M | $22M | $14M | $19M | $21M | $17M | $16M | |
| Shares Outstanding | 2,291,056 | 1,542,139 | 1,540,684 | 1,516,659 | 13,439,612 | 8,745,207 | 6,065,441 | 783,865 | 8,717,541 | 4,585,800 | 4,585,800 | 139,297,282 |
Flujo de Efectivo 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $0 | $0 | $1.0K | · | · | · | · | $56.1K | $88.7K | |
| Stock-based Comp | $64.8K | $171.8K | $283.1K | $511.5K | $410.4K | $468.9K | $806.1K | $1M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-2M | $-3M | $-4M | $-5M | $-5M | $-4M | $-6M | $-6M | $1M | $-9M | $-5M | $-13M | |
| CapEx | · | · | · | · | · | · | · | $0 | $9.3K | $16.8K | $1.7K | $57.7K | |
| Investing Cash Flow | · | · | $0 | $-500.0K | $0 | $0 | $2.0K | $22.5K | $-9.3K | $-16.8K | · | · | |
| Stock Issued | $4M | $0 | · | $0 | $11M | $5M | $0 | · | · | · | $0 | $10M | |
| Financing Cash Flow | $4M | $0 | · | $0 | $11M | $5M | $16M | $1M | $0 | $13M | · | · | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.0% | -1.6% | 48.8% | 47.1% | 165.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 20.4% | 29.1% | 79.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 46.8% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | $3M | $2M | $1M | $436.9K | $17.1K | $0 | $8M | $3M | $0 | $0 | |
| Net Income TTM | $-3M | $-4M | $-4M | $-7M | $-6M | $-11M | $-13M | $-7M | $-4M | $-54M | $-13M | $-14M | |
| P/E | -1.4 | -1.6 | -1.3 | -0.6 | -23.5 | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.7 | 1.0 | 0.5 | 3.2 | 9.4 | 14.6 | · | · | · | · | · | · | |
| Earnings Yield | -72.8% | -64.4% | -78.5% | -161.8% | -4.3% | · | · | · | · | · | · | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $660.6K | $806.9K | $766.3K | $1M | $589.9K | $593.3K | $648.8K | $614.2K | $726.4K | $510.8K | $672.0K | $611.2K | $651.0K | $605.8K | $487.0K | $414.2K | |
| R&D Expense | $552.0K | $661.4K | $773.4K | $756.5K | $656.6K | $879.0K | $1M | $368.0K | $933.8K | $944.3K | $975.6K | $1M | $903.2K | $595.3K | $1M | $398.8K | |
| SG&A Expense | $1M | $647.6K | $615.9K | $815.2K | $657.8K | $656.6K | $705.7K | $745.7K | $1M | $834.9K | $952.0K | $737.2K | $946.0K | $925.7K | $857.2K | $863.2K | |
| Operating Expenses | $2M | $1M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Operating Income | $-971.7K | $-502.1K | $-623.0K | $-544.7K | $-724.4K | $-942.4K | $-1M | $-499.5K | $-1M | $-1M | $-1M | $-1M | $-1M | $-915.2K | $-2M | $-847.8K | |
| Interest Income | $42.1K | $45.8K | · | · | $34.2K | $39.2K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-72 | $-21 | $159 | $4.0K | $1.5K | $78 | $-7.2K | $1.5K | $-21 | $52 | $404 | $-666 | $21.1K | $4.5K | $986 | $-1.7K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-929.7K | $-456.4K | $-579.1K | $-509.9K | $-688.7K | $-903.1K | $-1M | $-436.7K | $-1M | $-1M | $-1M | $-1M | $-1M | $-856.6K | $-1M | $-804.0K | |
| EPS (Basic) | $-0.41 | $-0.20 | $-0.21 | $-0.33 | $-0.45 | $-0.59 | $-0.68 | $-0.28 | $-0.83 | $-0.78 | $-0.77 | $-0.69 | $-0.69 | $-0.56 | $-2.03 | $-0.56 | |
| EPS (Diluted) | $-0.41 | $-0.20 | $-0.21 | $-0.33 | $-0.45 | $-0.59 | $-0.68 | $-0.28 | $-0.83 | $-0.78 | $-0.77 | $-0.69 | $-0.69 | $-0.56 | $-2.03 | $-0.56 | |
| Shares (Basic) | 2,294,364 | 2,291,056 | -2,924,846 | 1,542,139 | 1,542,139 | 1,542,139 | -3,081,866 | 1,541,722 | 1,540,799 | 1,540,684 | -3,045,766 | 1,532,600 | 1,524,717 | 1,516,659 | -14,855,930 | 1,431,659 | |
| Shares (Diluted) | 2,294,364 | 2,291,056 | -2,924,846 | 1,542,139 | 1,542,139 | 1,542,139 | -3,081,866 | 1,541,722 | 1,540,799 | 1,540,684 | -3,045,766 | 1,532,600 | 1,524,717 | 1,516,659 | -14,855,930 | 1,431,659 | |
| EBITDA | $-971.7K | $-502.1K | · | $-544.7K | $-724.4K | $-942.4K | · | $-499.5K | $-1M | $-1M | · | $-1M | $-1M | $-915.2K | · | $-847.8K |
Balance general 18
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $7M | · | · | · | $5M | · | $7M | $7M | $8M | $9M | $10M | $11M | $12M | $13M | $14M | |
| Prepaid Expense | $182.3K | $247.8K | $166.3K | $946.4K | $573.9K | $313.6K | $422.0K | $188.1K | $716.4K | $552.0K | $603.8K | $1M | $1M | $876.5K | $556.1K | $319.1K | |
| Current Assets | $7M | $8M | $8M | $5M | $5M | $5M | $7M | $7M | $8M | $8M | $10M | $11M | $12M | $13M | $14M | $14M | |
| Other Non-current Assets | $313.9K | $313.9K | $313.9K | $0 | $0 | $313.9K | $313.9K | $1M | $1M | $1M | $1M | $704.4K | $704.4K | $844.4K | $1M | $1M | |
| Total Assets | $7M | $8M | $8M | $5M | $5M | $6M | $7M | $8M | $9M | $9M | $11M | $12M | $13M | $14M | $15M | $16M | |
| Accounts Payable | $322.5K | $558.8K | $258.1K | $578.2K | $346.8K | $240.3K | $283.6K | $243.3K | $283.6K | $210.5K | $240.8K | $448.6K | $221.3K | $259.2K | $287.4K | $202.8K | |
| Accrued Liabilities | · | · | $709.9K | · | · | · | $610.6K | · | · | · | $568.8K | · | · | · | $785.8K | · | |
| Current Liabilities | $895.0K | $958.2K | $968.0K | $1M | $903.4K | $667.9K | $894.3K | $1M | $2M | $716.5K | $809.6K | $1M | $871.3K | $856.4K | $1M | $1M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Total Liabilities | $895.0K | $958.2K | $968.0K | $1M | $903.4K | $667.9K | $894.3K | $1M | $2M | $716.5K | $809.6K | $1M | $871.3K | $856.4K | $1M | $1M | |
| Common Stock | $2.3K | $2.3K | $2.3K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $15.2K | $1.5K | $14.3K | |
| Paid-in Capital | $212M | $212M | $212M | $208M | $208M | $208M | $208M | $208M | $208M | $208M | $208M | $208M | $208M | $208M | $208M | $207M | |
| Retained Earnings | $-201M | $-200M | $-200M | $-199M | $-199M | $-198M | $-197M | $-196M | $-196M | $-194M | $-193M | $-192M | $-191M | $-190M | $-189M | $-188M | |
| Treasury Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| AOCI | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | $253.7K | |
| Stockholders' Equity | $6M | $7M | $7M | $4M | $4M | $5M | $6M | $7M | $7M | $9M | $10M | $11M | $12M | $13M | $14M | $15M | |
| Liabilities + Equity | $7M | $8M | $8M | $5M | $5M | $6M | $7M | $8M | $9M | $9M | $11M | $12M | $13M | $14M | $15M | $16M | |
| Shares Outstanding | 2,343,181 | 2,293,757 | 2,291,056 | 1,542,139 | 1,542,139 | 1,542,139 | 1,542,139 | 1,542,139 | 1,541,101 | 1,540,684 | 1,540,684 | 1,532,600 | 1,532,600 | 15,166,596 | 1,516,659 | 14,316,596 |
Flujo de Efectivo 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $52.0K | $11.3K | $14.0K | $15.9K | $15.7K | $19.3K | $25.1K | $27.5K | $42.1K | $77.1K | $74.6K | $70.3K | $69.4K | $68.9K | $118.7K | $137.4K | |
| Operating Cash Flow | $-875.5K | $-536.4K | $-242.7K | $-658.2K | $-383.8K | $-1M | $-674.0K | $-459.0K | $-525.1K | $-1M | $-793.0K | $-949.6K | $-1M | $-1M | $-750.9K | $-1M | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -147.1% | -62.2% | · | -53.0% | -122.8% | -158.8% | · | -81.3% | -184.1% | -248.3% | · | -187.6% | -184.1% | -151.1% | · | -204.7% | |
| Net Margin | -140.7% | -56.6% | · | -49.7% | -116.8% | -152.2% | · | -71.1% | -175.4% | -234.0% | · | -172.7% | -161.4% | -141.4% | · | -194.1% | |
| EBITDA Margin | -147.1% | -62.2% | · | -53.0% | -122.8% | -158.8% | · | -81.3% | -184.1% | -248.3% | · | -187.6% | -184.1% | -151.1% | · | -204.7% | |
| ROA | -15.1% | -6.7% | · | -7.8% | -9.6% | -11.9% | · | -4.4% | -11.7% | -10.3% | · | -7.7% | -7.2% | -5.4% | · | -4.4% | |
| ROE | -17.7% | -7.6% | · | -9.3% | -11.6% | -13.1% | · | -4.9% | -13.2% | -11.1% | · | -8.3% | -7.8% | -5.8% | · | -4.6% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | 7.9 | · | 4.6 | 5.9 | 8.2 | · | 7.0 | 5.0 | 11.7 | · | 10.5 | 13.8 | 15.0 | · | 13.5 | |
| Quick Ratio | · | 7.7 | · | · | · | 7.7 | · | 6.8 | 4.6 | 10.9 | · | 9.1 | 12.3 | 14.0 | · | 13.2 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valoración (TTM) 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $3M | $3M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-3M | $-3M | · | $-3M | $-3M | $-4M | · | $-4M | $-5M | $-4M | · | $-4M | $-5M | $-6M | · | $-6M | |
| Market Cap | $7M | $6M | · | $5M | $6M | $4M | · | $7M | $6M | $6M | · | $8M | $5M | $62M | · | $77M | |
| P/E | -2.1 | -1.7 | · | -1.9 | -1.8 | -1.1 | · | -1.7 | -1.4 | -1.4 | · | -2.0 | -0.9 | -1.3 | · | -2.0 | |
| P/S | 2.2 | 2.0 | · | 1.7 | 2.4 | 1.6 | · | 2.7 | 2.5 | 2.4 | · | 3.3 | 2.4 | 33.7 | · | 49.0 | |
| P/B | 1.1 | 0.9 | · | 1.2 | 1.4 | 0.8 | · | 0.9 | 0.8 | 0.7 | · | 0.7 | 0.4 | 4.8 | · | 5.3 | |
| P / Tangible Book | 1.1 | 0.9 | · | 1.2 | 1.4 | 0.8 | · | 0.9 | 0.8 | 0.7 | · | 0.7 | 0.4 | 4.8 | · | 5.3 | |
| P / Cash Flow | · | -11.5 | · | · | · | -4.0 | · | · | · | -5.0 | · | · | · | -55.9 | · | · | |
| Earnings Yield | -47.8% | -58.6% | · | -52.5% | -54.9% | -95.0% | · | -59.7% | -73.5% | -72.2% | · | -51.0% | -113.1% | -77.3% | · | -50.5% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $3M | $3M | $3M | $2M | $1M |
| Beneficio neto | $-3M | $-4M | $-4M | $-7M | $-6M |
| EPS Diluido | $-1.58 | $-2.57 | $-2.71 | $-4.61 | $-0.55 |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 8 declarantes · $422K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 3 (+3 vs trimestre anterior) | 0 (-5 vs trimestre anterior) | 0 (-1 vs trimestre anterior) | 3 (+1 vs trimestre anterior) | -10K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $341 750 | 117 440 | 80,90% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $38 388 | 13 184 | 9,09% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $36 902 | 12 681 | 8,74% | Acciones |
| SBI Securities Co., Ltd. | $2 910 | 1 000 | 0,69% | Acciones |
| Tower Research Capital LLC (TRC) | $2 025 | 696 | 0,48% | Acciones |
| MORGAN STANLEY | $437 | 150 | 0,10% | Acciones |
| JTC Employer Solutions Trustee Ltd | $8 | 2 700 | 0,00% | Acciones |
| Darwin Wealth Management, LLC | $5 | 2 | 0,00% | Acciones |
Informantes de la empresa 1 insider · 1 directivos · 0 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| James F Parslow | Chief Financial Officer | 3 de abril de 2017 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| CLS Therapeutics, LLC, CLS Therapeutics Ltd., Dmitry Genkin, Victor Tets, Georgy Tets, M. Scott Maguire ×3 presentaciones | 18 de marzo de 2024 | — | Presentación inicial | — | SEC |
| PJSC Pharmsynthez, LLC SynBio, Dmitry Genkin | 13 de julio de 2017 | — | Presentación inicial | — | SEC |
| Michael Scott Maguire | 22 de noviembre de 2016 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 12 681 SH | 8 de agosto de 2026 | Diario |